® Consulta de Marcas Base do INPI · pesquisa e monitoramento

UPYTHA

Registro de marca em vigor (Madri)

Marca Nominativa depositada no INPI em 22/06/2022 por Ascendis Pharma Endocrinology Division A/S, processo nº 501702814, nas classes 05, 09, 10. Registro em vigor até 22/06/2032.

Número do processo501702814
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito22/06/2022
Data da concessão23/01/2024
Vigência até22/06/2032
TitularAscendis Pharma Endocrinology Division A/S
CNPJ/CPF do titular
UF · País— · DK

Classes e especificação

Classe 05 — Farmacêuticos e saúde

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders.;

Classe 09 — Software e eletrônicos

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their authorization and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders. dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.;

Classe 10 — Aparelhos médicos

Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; software controlled drug delivery medical devices for medicine dosage and for providing web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; software controlled drug delivery medical devices for dosage management, and for use in medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patient remotely and at a clinic.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501702814 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

3 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 23/01/2024 Concessão de registro em designação código IPAS770 · RPI 2768
  2. 03/10/2023 Deferimento de designação código IPAS768 · RPI 2752
  3. 02/05/2023 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2730

Outras marcas de Ascendis Pharma Endocrinology Division A/S